|
TCMBANKIN000288 |
(1R,2R,4R)-Dihydrocarveol |
(1R,2R,5R)-5-Isopropenyl-2-methylcyclohexanol; LMPR01020079; (1R,2R,5R)-2-methyl-5-prop-1-en-2-ylcyclohexan-1-ol; (1R,2R,5R)-5-isopropenyl-2-methyl-1-cyclohexanol; (−)-Dihydrocarveol; C11396; (1R,2R,5R)-5-isopropenyl-2-methyl-cyclohexan-1-ol; 37278_FLUKA; (1R,2R,5R)-2-methyl-5-prop-1-en-2-yl-cyclohexan-1-ol |
C10H18O |
154.25 |
CC1CCC(CC1O)C(=C)C |
|
TCMBANKIN000349 |
(E)-2-propenoic acid,3-(3-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl),methyl ester |
|
|
224.33 |
|
|
TCMBANKIN000405 |
1,5-diethyl-2,3-dimethylcyclohexylamine |
|
|
183.38 |
|
|
TCMBANKIN000725 |
4,4'-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2-methoxyphenol) |
phenol, 4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2-methoxy-; InChI=1/C20H22O6/c1-23-17-7-11(3-5-15(17)21)19-13-9-26-20(14(13)10-25-19)12-4-6-16(22)18(8-12)24-2/h3-8,13-14,19-22H,9-10H2,1-2H; 4-[(1R,3aR,4S,6aR)-4-(4-hydroxy-3-methoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2-methoxy-phenol; 4-[(1R,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2-methoxyphenol; PINORESINOL MFC20 H22 O6 |
C20H22O6 |
358.39 |
COC1=C(C=CC(=C1)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC)O |
|
TCMBANKIN000991 |
dan-shexinkum b |
|
|
280.34 |
|
|
TCMBANKIN001325 |
2-[(1R)-4-methyl-1-cyclohex-3-enyl]propan-2-yl acetate |
acetic acid [1-methyl-1-[(1R)-4-methyl-1-cyclohex-3-enyl]ethyl] ester; 2-[(1R)-4-methyl-1-cyclohex-3-enyl]propan-2-yl ethanoate; [1-methyl-1-[(1R)-4-methyl-1-cyclohex-3-enyl]ethyl] acetate |
C12H20O2 |
196.29 |
|
|
TCMBANKIN001550 |
Caproleic acid |
W366005_ALDRICH; 9-Decenoic acid; FEMA No. 3660; dec-9-enoic acid; 14436-32-9; 9-decylenic acid; EINECS 238-410-9; Delta(9)-decenoic acid; CHEBI:32381; LMFA01030033 |
C10H18O2 |
170.25 |
C=CCCCCCCCC(=O)O |
|
TCMBANKIN002128 |
[(3R)-3,7-dimethylocta-1,6-dien-3-yl] acetate |
LMPR01020058; ZINC01531613; [(3R)-3,7-dimethylocta-1,6-dien-3-yl] ethanoate; acetic acid [(1R)-1,5-dimethyl-1-vinylhex-4-enyl] ester; C09863; acetic acid [(1R)-1,5-dimethyl-1-vinyl-hex-4-enyl] ester; [(1R)-1,5-dimethyl-1-vinyl-hex-4-enyl] acetate |
C12H20O2 |
196.29 |
CC(=CCCC(C)(C=C)OC(=O)C)C |
|
TCMBANKIN002169 |
Isobutyl octanoate |
Octanoic acid, 2-methylpropyl ester; caprylic acid isobutyl ester; 2-methylpropyl octanoate; n-Caprylic acid isobutyl ester; NSC 23943; AI3-31003; Isobutyl caprylate (natural); NSC23943; 5461-06-3; octanoic acid isobutyl ester; EINECS 226-744-8; Octanoic acid, isobutyl ester; iso-Butyl caprylate; Isobutyl caprylate |
C12H24O2 |
200.32 g/mol |
CCCCCCCC(=O)OCC(C)C |
|
TCMBANKIN002258 |
Glepidotin A |
8-(3,3-Dimethylallyl)galangin; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenylchromen-4-one; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chromen-4-one; 8-(3,3-DMA)galangin; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chromone; glepidotin a; 42193-83-9; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-4-chromenone; 8-Prenylgalangin; C10049 |
C20H18O5 |
338.35 |
CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=CC=C3)O)C |
|
TCMBANKIN002452 |
methyl 8-methyl-decanoate |
|
C12H24O2 |
200.32 g/mol |
CCC(C)CCCCCCC(=O)OC |
|
TCMBANKIN002513 |
hirsutin_qt |
|
|
345.35 |
|
|
TCMBANKIN002723 |
7,2'-dihydroxy-5,8-dimethoxyflavone |
|
|
314.31 |
|
|
TCMBANKIN003248 |
(2R,4aS,10aR)-7-isopropyl-2,4a-dimethyl-1-methylene-4,9,10,10a-tetrahydro-3H-phenanthren-2-ol |
(2R,4aS,10aR)-2,4a-dimethyl-1-methylidene-7-propan-2-yl-4,9,10,10a-tetrahydro-3H-phenanthren-2-ol |
|
284.48 |
|
|
TCMBANKIN003805 |
TDA |
91988_FLUKA; NSC 69131; 4-02-00-01117 (Beilstein Handbook Reference); NSC 25955; EINECS 211-341-1; T0502_SIGMA; (C10-C16)Alkylcarboxylic acid; EINECS 268-105-6; Tridecanoic acid; LMFA01010013; NSC69131; AI3-04166; 638-53-9; 68002-90-4; Fatty acids, C10-16; (C10-C16) Carboxylic acid; n-Tridecanoic acid; NCIOpen2_003250; WLN: QV12; n-Tridecoic acid; TRIDECYLIC ACID; CHEBI:45919; BRN 0508317; NSC25955 |
C13H26O2 |
214.34 |
CC1=C(C=C(C=C1)N)N |
|
TCMBANKIN004210 |
1-methoxy-2-hydroxyanthraquinone |
Anthraquinone, 2-hydroxy-1-methoxy-; Alizarin-1-methylether; 2-Hydroxy-1-methoxy-anthraquinone; AIDS098147; Alizarin-1-methyl ether; 2-hydroxy-1-methoxy-anthracene-9,10-dione; 9,10-Anthracenedione, 2-hydroxy-1-methoxy-; 2-hydroxy-1-methoxy-9,10-anthraquinone; 6170-06-5; Alizarin 1-methyl ether; AIDS-098147; 2-hydroxy-1-methoxyanthracene-9,10-dione |
C15H10O4 |
254.24 g/mol |
COC1=C(C=CC2=C1C(=O)C3=CC=CC=C3C2=O)O |
|
TCMBANKIN004570 |
n-butyl-O-β-D-fruct opyranoside |
n-butyl-O-β-D-fructopyranoside |
|
222.27 |
|
|
TCMBANKIN004704 |
1-alpha-Terpinyl acetate |
(R)-alpha,alpha,4-Trimethylcyclohex-3-ene-1-methyl acetate; 2-[(1S)-4-methyl-1-cyclohex-3-enyl]propan-2-yl acetate; 3-Cyclohexene-1-methanol, alpha,alpha,4-trimethyl-, acetate, (theta)-; [1-methyl-1-[(1S)-4-methyl-1-cyclohex-3-enyl]ethyl] acetate; (S)-alpha,alpha,4-Trimethylcyclohex-3-ene-1-methyl acetate; acetic acid [1-methyl-1-[(1S)-4-methyl-1-cyclohex-3-enyl]ethyl] ester; 3-Cyclohexene-1-methanol, alpha,alpha,4-trimethyl-, acetate, (1R)-; EINECS 232-082-0; 2-[(1S)-4-methyl-1-cyclohex-3-enyl]propan-2-yl ethanoate; EINECS 261-165-4; 58206-95-4; 3-Cyclohexene-1-methanol, alpha,alpha,4-trimethyl-, acetate, (S)-; 3-Cyclohexene-1-methanol, alpha,alpha,4-trimethyl-, acetate, (1S)-; 7785-54-8 |
C12H20O2 |
196.29 |
CC1=CCC(CC1)C(C)(C)OC(=O)C |
|
TCMBANKIN004792 |
gamma-Terpineol |
4-isopropylidene-1-methyl-cyclohexan-1-ol; 586-81-2; 1-Methyl-4-(1-methylethylidene)cyclohexan-1-ol; Cyclohexanol, 1-methyl-4-(1-methylethylidene)-; 4-isopropylidene-1-methyl-1-cyclohexanol; TERPINEOL, GAMMA; .gamma.-Terpineol; EINECS 209-584-3; 1-methyl-4-propan-2-ylidene-cyclohexan-1-ol; 1-methyl-4-propan-2-ylidenecyclohexan-1-ol |
C10H18O |
154.25 |
CC(=C1CCC(CC1)(C)O)C |
|
TCMBANKIN004839 |
GCS |
AIDS000694; 14257-69-3; 6490-70-6 (.ALPHA.-FORM); C08349; KBioGR_000970; Spectrum5_000756; (2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)tetrahydropyran-2,4,5-triol; BSPBio_002086; beta-D-Glucosamine; KBio2_001311; IDI1_000261; (2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol; KBio3_001306; CHEBI:28393; SPBio_000477; 90-77-7; NINDS_000261; (2R,3R,4R,5S,6R)-3-amino-6-methylol-tetrahydropyran-2,4,5-triol; KBio2_003879; Spectrum2_000519; D-Glucose, 2-deoxy-2-Amino-; KBio1_000261; AIDS-000694; KBio2_006447; Spectrum3_000443; Spectrum4_000565; Spectrum_000831; KBioSS_001311; 28905-10-4 (.BETA-FORM); DivK1c_000261 |
C6H13NO5 |
179.17 |
C(C1C(C(C(C(O1)O)N)O)O)O |
|
TCMBANKIN004875 |
(2R,3S,4S,5R)-2-ethoxy-2,5-bis(hydroxymethyl)oxolane-3,4-diol |
(2R,3S,4S,5R)-2-ethoxy-2,5-dimethylol-tetrahydrofuran-3,4-diol; (2R,3S,4S,5R)-2-ethoxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3,4-diol |
C8H16O6 |
208.21 |
CCOC1(C(C(C(O1)CO)O)O)CO |
|
TCMBANKIN005164 |
(2S,3R,4S,5S,6R)-2-ethoxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol |
(2S,3R,4S,5S,6R)-2-ethoxy-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-ethoxy-6-(hydroxymethyl)oxane-3,4,5-triol |
|
208.24 |
|
|
TCMBANKIN005518 |
thymoquinol 2-glucoside |
|
|
328.4 |
|
|
TCMBANKIN005796 |
secologanic acid_qt |
|
|
212.22 |
|
|
TCMBANKIN005952 |
geniposidie acid_qt |
Genioisidic acid_qt; geniposidic acid_qt; geniposidic,acid_qt |
C16H22O10 |
374.34 |
|
|
TCMBANKIN006022 |
1,2-Cyclohexanediol,1-methyl-4-(1-methylethyl) |
|
C10H20O2 |
172.26 g/mol |
CC(C)C1CCC(C(C1)O)(C)O |
|
TCMBANKIN006300 |
(3R)-undec-1-en-3-ol |
|
C11H22O |
170.29 |
|
|
TCMBANKIN006587 |
(-)-angelicoidenol-2-O-β-D-glucopyranoside_qt |
|
|
200.36 |
|
|
TCMBANKIN006814 |
Isoamyl caproate |
Isopentyl hexanoate; Hexanoic acid, isopentyl ester; BRN 1760611; FEMA No. 2075; EINECS 218-600-8; 3-Methylbutyl hexanoate; Isopentyl-n-hexanoate; ST5410080; Isopentyl caproate; ISOAMYL HEXANOATE; AI3-00573; Isoamyl hexanoate (natural); W207500_ALDRICH; hexanoic acid isopentyl ester; hexanoic acid isoamyl ester; 2198-61-0; Hexanoic acid, 3-methylbutyl ester; 3-02-00-00727 (Beilstein Handbook Reference); W207519_ALDRICH; Isopentyl alcohol, hexanoate |
C11H22O2 |
186.29 |
CCCCCC(=O)OCCC(C)C |
|
TCMBANKIN007095 |
Dibutyl acetal |
Acetaldehyde dibutyl acetal; Ethane, 1,1-dibutoxy-; 871-22-7; 1,1-Dibutoxyethane; WLN: 4OYO4; NSC 5314; EINECS 212-804-0; 1,1'-(Ethylidenebis(oxy))bisbutane; BRN 1698922; AI3-22404; 1,1-Di-n-butoxyethane; Di-n-butyl acetal; NSC5314; 6-Methyl-5,7-dioxaundecane; Acetaldehyde, dibutyl acetal; 1-(1-butoxyethoxy)butane; Butane, 1,1'-[ethylidenebis(oxy)]bis-; Butane, 1,1'-(ethylidenebis(oxy))bis- (9CI); 1,1'-(Ethylidenebis(oxy))dibutane |
C10H22O2 |
174.28 |
CCCCOC(C)OCCCC |
|
TCMBANKIN008402 |
leonuriside,b |
|
C25H38O16 |
594.56 |
|
|
TCMBANKIN008452 |
(E)-Linalol pyranoxide |
linalool oxide C (trans-THP); (3S,6R)-6-ethenyl-2,2,6-trimethyl-oxan-3-ol; (3S,6R)-6-ethenyl-2,2,6-trimethyloxan-3-ol; (3S,6R)-2,2,6-trimethyl-6-vinyl-3-tetrahydropyranol; (3S,6R)-2,2,6-trimethyl-6-vinyl-tetrahydropyran-3-ol; (E)-Linallol oxide (pyran) |
C21H44 |
296.57 |
CC1(C(CCC(O1)(C)C=C)O)C |
|
TCMBANKIN008887 |
d-isomenthone |
EINECS 214-813-5; (2R,5R)-2-isopropyl-5-methyl-1-cyclohexanone; Cyclohexanone, 5-methyl-2-(1-methylethyl)-, (2R-cis)-; (2R,5R)-5-methyl-2-propan-2-yl-cyclohexan-1-one; (2R,5R)-2-isopropyl-5-methylcyclohexanone; 18309-28-9; 1196-31-2; (2R,5R)-2-isopropyl-5-methyl-cyclohexan-1-one; (2R-cis)-5-methyl-2-(1-methylethyl)cyclohexanone; ZINC03860577; (+)-Isomenthone; (1R,4R)-p-menthan-3-one; EINECS 242-194-1; C11952; LMPR01020096; (2R,5R)-5-methyl-2-propan-2-ylcyclohexan-1-one; (2R,5R)-5-methyl-2-(propan-2-yl)cyclohexanone; CHEBI:36492; (2S-cis)-2-(Isopropyl)-5-methylcyclohexan-1-one |
C10H18O |
154.25 |
CC1CCC(C(=O)C1)C(C)C |
|
TCMBANKIN009244 |
13657-68-6 |
Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))-; (3S,6E,10S)-3-isopropyl-6,10-dimethyl-cyclodec-6-ene-1,4-dione; (3S,6E,10S)-6,10-dimethyl-3-propan-2-ylcyclodec-6-ene-1,4-dione; (3S,6E,10S)-3-isopropyl-6,10-dimethylcyclodec-6-ene-1,4-dione; 6-Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))- (9CI); Germacr-1(10)-ene-5,8-dione; (3S,6E,10S)-6,10-dimethyl-3-propan-2-yl-cyclodec-6-ene-1,4-dione; (3S,6E,10S)-3-isopropyl-6,10-dimethyl-cyclodec-6-ene-1,4-quinone |
C15H24O2 |
236.35 |
CC1CCC=C(CC(=O)C(CC1=O)C(C)C)C |
|
TCMBANKIN009420 |
Ethyl glucoside |
(2R,3R,4S,5S,6R)-2-ethoxy-6-methylol-tetrahydropyran-3,4,5-triol; Glucoside, ethyl, D-; (2R,3R,4S,5S,6R)-2-ethoxy-6-(hydroxymethyl)oxane-3,4,5-triol; 30285-48-4; beta-D-Glucopyranoside, ethyl; 3198-49-0; (2R,3R,4S,5S,6R)-2-ethoxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; Ethyl D-glucoside; EINECS 250-112-0 |
C8H16O6 |
208.21 |
CCOC1C(C(C(C(O1)CO)O)O)O |
|
TCMBANKIN009629 |
tangshenoside I_qt |
|
C29H42O18 |
678.63 |
|
|
TCMBANKIN009775 |
Betavulgarin |
7-(2-hydroxyphenyl)-9-methoxy-8-pyrano[2,3-f][1,3]benzodioxolone; 7-(2-hydroxyphenyl)-9-methoxy-pyrano[2,3-f][1,3]benzodioxol-8-one; 7-(2-hydroxyphenyl)-9-methoxypyrano[2,3-f][1,3]benzodioxol-8-one; 51068-94-1; C10201 |
C17H12O6 |
312.27 |
COC1=C2C(=CC3=C1OCO3)OC=C(C2=O)C4=CC=CC=C4O |
|
TCMBANKIN010845 |
(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid |
(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxy-oxane-2-carboxylic acid; (2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4,5,6-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-methylol-tetrahydropyran-2-yl]oxy-4,5,6-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4R,5R,6R)-3-[[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4,5,6-trihydroxy-2-tetrahydropyrancarboxylic acid |
|
381.38 |
|
|
TCMBANKIN011663 |
1,5,7-trihydroxy-6-methoxy-2-methoxymethylanthracenequinone |
|
|
330.31 |
|
|
TCMBANKIN012123 |
cis-Piperitol |
cis-6-(Isopropyl)-3-methylcyclohex-2-en-1-ol; 16721-38-3; (1R,6S)-3-methyl-6-propan-2-ylcyclohex-2-en-1-ol; (1R,6S)-6-isopropyl-3-methyl-1-cyclohex-2-enol; EINECS 240-775-4; (1R,6S)-6-isopropyl-3-methyl-cyclohex-2-en-1-ol; 75363-64-3; 2-Cyclohexen-1-ol, 3-methyl-6-(1-methylethyl)-, (1R,6S)-rel-; cis-piperitol; (1R,6S)-3-methyl-6-propan-2-yl-cyclohex-2-en-1-ol |
C10H18O |
154.25 |
CC1=CC(C(CC1)C(C)C)O |
|
TCMBANKIN012291 |
n-butyl-α-D-fructopyranoside |
n butyl-α-D-fructopyranoside |
|
236.3 |
|
|
TCMBANKIN012351 |
Schizonepetoside C_qt |
|
|
168.26 |
|
|
TCMBANKIN012539 |
2-Octadecanone |
74733_FLUKA; Hexadecyl methyl ketone; Methyl n-hexadecyl ketone; NSC101084; octadecan-2-one; 7373-13-9 |
C18H36O |
268.48 |
CCCCCCCCCCCCCCCCC(=O)C |
|
TCMBANKIN012639 |
Cyclohexanone,2-butyl |
|
C10H18O |
154.25 g/mol |
CCCCC1CCCCC1=O |
|
TCMBANKIN012805 |
Cruex |
Caswell No. 901; C13910; Kyselina undecylenova [Czech]; Sevinon; Undecylenic acid (JAN/USP); 112-38-9; Undecenoic acid, omega-; 10-Hendecenoic; NCGC00159425-03; WLN: QV9U1; 10-Undecylenic acid; NCI60_001670; D02159; SBB009049; AIDS108286; 10-Hendecenoic acid; NSC2013; EPA Pesticide Chemical Code 085501; NSC 2013; omega-undecenoic acid; Kyselina 9-decen-1-karboxylova [Czech]; Undecylenic acid [JAN]; 10-Henedecenoic acid; EINECS 215-583-9; NCGC00159425-02; Declid; Renselin; W324701_ALDRICH; BRN 1762631; 94192_FLUKA; omega-hendecenoic acid; Desenex solution; CHEBI:35045; EINECS 203-965-8; 1-Undecenoic acid; component of Desenex; Desenex, solution; Undecyl-10-enic acid; Undecenoic acid; AI3-02065; AIDS-108286; FEMA No. 3247; Desenex; 124672_ALDRICH; 10-Undecenoic acid; LMFA01030036; 27817_RIEDEL; Undec-10-enoic acid; 1333-28-4; 9-Undecylenic acid; InChI=1/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13; Hendecenoic acid, omega-; NCIOpen2_002642; 4-02-00-01612 (Beilstein Handbook Reference); Undecylenic acid; Cruex (TN) |
C11H20O2 |
184.28 |
C=CCCCCCCCCC(=O)O |
|
TCMBANKIN013004 |
1-(1-ethoxyethoxy)hexane |
1-(1-ethoxyethoxy)-hexane |
C10H22O2 |
174.28 g/mol |
CCCCCCOC(C)OCC |
|
TCMBANKIN013215 |
1-methyl-8,9-dihydro-7H-naphtho[5,6-g]benzofuran-6,10,11-trione |
1-methyl-8,9-dihydro-7H-naphtho[5,6-g][1]benzoxole-6,10,11-trione |
C17H12O4 |
280.27 |
|
|
TCMBANKIN013593 |
jioglutin E |
jioglutin e |
C11H20O5 |
232.27 g/mol |
CC1(CC(C2C1C(OC(C2)OC)OC)O)O |
|
TCMBANKIN014177 |
threo-austrobailignan-5 |
|
|
326.42 |
|
|
TCMBANKIN014414 |
tanshinone Ⅵ |
|
296.34 |
45.637306 |
|
|
TCMBANKIN014671 |
miltionone Ⅰ |
|
312.39 |
49.684394 |
|
|
TCMBANKIN015021 |
1,5,6-trimethoxyphenanthrene-2,7-diol |
|
C17H16O5 |
300.31 |
|
|
TCMBANKIN015054 |
cis-linalol pyranoxide |
linalool oxide D (cis-THP); cis-Linalool Oxide, pyranoid; (3R,6R)-6-ethenyl-2,2,6-trimethyloxan-3-ol; (3R,6R)-2,2,6-trimethyl-6-vinyl-3-tetrahydropyranol; (3R,6R)-6-ethenyl-2,2,6-trimethyl-oxan-3-ol; cis-Linalol oxide (pyranoid); (3R,6R)-2,2,6-trimethyl-6-vinyl-tetrahydropyran-3-ol |
C10H18O2 |
170.25 g/mol |
CC1(C(CCC(O1)(C)C=C)O)C |
|
TCMBANKIN015058 |
4',5,7-trihydroxy-6-methyl-8-methoxy-homoisoflavanone |
|
|
330.36 |
|
|
TCMBANKIN015169 |
schizonepetoside E_qt |
|
|
186.28 |
|
|
TCMBANKIN016181 |
Chrysosplenetin |
5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-4-chromenone; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; chrysosplenetin; 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromone; Quercetagetin 3,6,7,3'-tetramethyl ether; 4H-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; Chrysosplenetin B; 603-56-5; 69234-29-3; C10030 |
C19H18O8 |
374.34 |
COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
|
TCMBANKIN016213 |
Zingiberenol |
zingiberenol |
C15H26O |
222.37 |
CC(CCC=C(C)C)C1CCC(C=C1)(C)O |
|
TCMBANKIN016238 |
AMG |
Methyl alpha-D-galactopyranoside; 34004-14-3; (2S,3R,4S,5R,6R)-2-methoxy-6-methylol-tetrahydropyran-3,4,5-triol; ALPHA-METHYL-D-GALACTOSIDE; Methyl alpha-D-galactoside; M1379_SIGMA; ZINC04262102; EINECS 222-251-7; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methoxytetrahydropyran-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methoxy-tetrahydropyran-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methoxy-oxane-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol; 66916_FLUKA |
C7H16O7 |
212.2 g/mol |
COC1C(C(C(C(O1)CO)O)O)O.O |
|
TCMBANKIN016793 |
Inermine |
C10502; (-)-Maackiain; 6H-(1,3)Dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol, 6a,12a-dihydro-, (6aR-cis)-; ST077155; 2035-15-6 |
C16H12O5 |
284.26 |
C1C2C(C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5 |
|
TCMBANKIN017306 |
()-Isopulegol |
ZINC01081211; 439053_ALDRICH; (1S,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol; (1S,2R,5S)-2-isopropenyl-5-methyl-cyclohexan-1-ol; (1S,3S,4R)-p-Menth-8-en-3-ol; 59765_FLUKA; (1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol; (1S,2R,5S)-5-methyl-2-prop-1-en-2-yl-cyclohexan-1-ol; (1S,2R,5S)-2-isopropenyl-5-methyl-1-cyclohexanol |
C10H18O |
154.25 |
|
|
TCMBANKIN017374 |
Isobutyl caproate |
FEMA No. 2202; W220205_ALDRICH; AI3-24254; W220213_ALDRICH; Hexanoic acid, 2-methylpropyl ester; 2-Methyl-1-propyl caproate; Isobutyl caproate (natural); hexanoic acid isobutyl ester; EINECS 203-332-6; 105-79-3; Isobutyl hexanoate; Hexanoic acid, isobutyl ester; 2-METHYLPROPYL HEXANOATE |
C10H20O2 |
172.26 |
CCCCCC(=O)OCC(C)C |
|
TCMBANKIN018414 |
Aseanostatin P1 |
Tridecanoic acid, 12-methyl; CHEBI:43722; LMFA01020007; 12-methyl-tridecanoic acid; 12-methyltridecylic acid; 12-Methyltridecanoic acid; 2724-57-4; M7281_SIGMA; Tridecanoic acid, 12-methyl-; ISOMYRISTIC ACID; (+)-Isomyristic acid |
C14H28O2 |
228.37 |
CC(C)CCCCCCCCCCC(=O)O |
|
TCMBANKIN018460 |
dihydrotanshinlactone |
|
|
266.31 |
|
|
TCMBANKIN019898 |
tangshenoside III_qt |
|
|
402.48 |
|
|
TCMBANKIN020013 |
octadec-7-enoic acid |
7E-octadecenoic acid; (E)-octadec-7-enoic acid; LMFA01030069; trans-7-octadecenoic acid |
C18H34O2 |
282.5 g/mol |
CCCCCCCCCCC=CCCCCCC(=O)O |
|
TCMBANKIN020714 |
RAM |
ALPHA-RHAMNOSE; 6-deoxy-alpha-L-mannopyranose; alpha-L-rhamnopyranose; (2R,3R,4R,5R,6S)-6-methyltetrahydropyran-2,3,4,5-tetrol; alpha-L-Rha; CHEBI:27907; alpha-L-Mannomethylose; alpha-6-Deoxy-L-mannose; ZINC03861280; CHEBI:27848; alpha-L-Rhamnose; C02476; RAA; alpha-L-rhamnosides; alpha-L-Rhamnoside; 6-deoxy-alpha-L-mannopyranoside; (2R,3R,4R,5R,6S)-6-methyloxane-2,3,4,5-tetrol; 10030-85-0 |
C6H14O6 |
182.17 g/mol |
CC(C(C(C(C=O)O)O)O)O.O |
|
TCMBANKIN020752 |
(13aS)-2,3,10-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-9-ol |
|
C20H23NO4 |
341.4 |
|
|
TCMBANKIN020787 |
14-pentadecenoic acid |
pentadec-14-enoic acid; LMFA01030053 |
C15H28O2 |
240.38 |
C=CCCCCCCCCCCCCC(=O)O |
|
TCMBANKIN020824 |
1,2-diethyl-3-methylcyclohexylamine |
|
|
169.35 |
|
|
TCMBANKIN020999 |
3-isopropyl-6-isobutyl-2,5-piperazinedione |
|
C11H20N2O2 |
212.29 |
|
|
TCMBANKIN021112 |
SKM |
3,4,5-Trihydroxy-1-cyclohexenecarboxylic acid; C00493; HSDB 3537; CHEBI:16119; (3R,4S,5R)-(−)-3,4,5-Trihydroxy-1-cyclohexenecarboxylic acid; S5375_SIGMA; SMP1_000326; KBio2_001712; 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R-(3alpha,4alpha,5beta)); KBio1_001528; (3R,4S,5R)-(-)-3,4,5-Trihydroxy-1-cyclohexenecarboxylic acid; SPBio_001555; SDCCGMLS-0066740.P001; 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R-(3alpha,4alpha,5beta))-; NSC 59257; SPECTRUM1502256; EINECS 205-334-2; KBio2_006848; Shikimic acid [3R-(3alpha,4alpha,5beta)]-3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid; L-Shikimic acid; InChI=1/C7H10O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,4-6,8-10H,2H2,(H,11,12)/t4-,5-,6-/m1/s; NCGC00142601-01; KBioSS_001712; 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R,4S,5R)- (9CI); SBB012371; (3R,4S,5R)-3,4,5-trihydroxy-1-cyclohexenecarboxylic acid; Spectrum3_001541; (3R,4S,5R)-3,4,5-trihydroxycyclohexene-1-carboxylic acid; 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R-(3alpha,4alpha,5beta))- (9CI); KBio2_004280; Spectrum2_001508; (3R,4S,5R)-3,4,5-Trihydroxycyclohex-1-enecarboxylic acid; (-)-Shikimic acid; BSPBio_002982; CCRIS 7681; 1-cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R,4S,5R)-; KBio3_002482; MEGxp0_001939; Spectrum5_000386; SpecPlus_000488; DHK; Spectrum4_001853; DivK1c_006584; [3R-(3alpha,4alpha,5beta)]-3,4,5-trihydroxy-1-cyclohexene-1-carboxylic acid; Spectrum_001232; 3alpha,4alpha,5beta-Trihydroxy-1-cyclohexene-1-carboxylic acid; SR-01000632403-1; KBioGR_002287; (-)-3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid; S-5181; (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX-1-ENE-1-CARBOXYLIC ACID |
C7H10O5 |
174.15 |
CC(C)(C)OC(=O)N1C2=C(C=N1)C(=CC=C2)Br |
|
TCMBANKIN021171 |
dan-shexinkum d |
|
|
336.41 |
|
|
TCMBANKIN021284 |
alpha-D-glucuronic acid |
(2S,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid; (2S,3S,4S,5R,6S)-3,4,5,6-tetrahydroxytetrahydropyran-2-carboxylic acid; alpha-D-glucopyranuronic acid; CHEBI:42717; (2S,3S,4S,5R,6S)-3,4,5,6-tetrahydroxy-2-tetrahydropyrancarboxylic acid |
C48H74O20 |
971.09 |
C1(C(C(OC(C1O)O)C(=O)O)O)O |
|
TCMBANKIN021536 |
(Z)-9-Pentadecenoic acid |
(E)-pentadec-9-enoic acid; 1903-03-3; 9-Pentadecenoic acid, (Z)- |
C26H46N8O10 |
630.69 |
CCCCCC=CCCCCCCCC(=O)O |
|
TCMBANKIN021676 |
1-hydroxyethyl)-2,6-dihydroxy-1,7-dimethyl-9,10-dihydrophenanthrene |
|
C18H20O3 |
284.38 |
|
|
TCMBANKIN021895 |
pectin |
(2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxy-2-tetrahydropyrancarboxylic acid; 14982-50-4; (2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid; GTR; C08348; Galacturonic acid; (2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxytetrahydropyran-2-carboxylic acid |
C6H10O7 |
194.14 |
C1(C(C(OC(C1O)O)C(=O)O)O)O |
|
TCMBANKIN021929 |
(1S,2S,5S)-2-isopropyl-5-methyl-1-cyclohexanol |
(1S,2S,5S)-5-methyl-2-propan-2-yl-cyclohexan-1-ol; ZINC02038603; (1S,2S,5S)-5-methyl-2-propan-2-ylcyclohexan-1-ol; (1S,2S,5S)-2-isopropyl-5-methyl-cyclohexan-1-ol |
C10H20O |
156.27 |
|
|
TCMBANKIN021964 |
1-isobutyl-2,5-dimethylcyclohexylamine |
|
|
183.38 |
|
|
TCMBANKIN022832 |
Duartin |
101311-04-0; (3R)-3-(3-hydroxy-2,4-dimethoxy-phenyl)-8-methoxy-chroman-7-ol; 7,3'-Dihydroxy-2',4',8-trimethoxyisoflavan; KBio2_006426; KBioGR_001943; DivK1c_006984; KBioSS_001290; Spectrum4_001602; Spectrum_000810; KBio2_001290; SpecPlus_000888; (3R)-3-(3-hydroxy-2,4-dimethoxyphenyl)-8-methoxychroman-7-ol; Spectrum5_000323; (3R)-3-(3-hydroxy-2,4-dimethoxyphenyl)-8-methoxy-7-chromanol; KBio2_003858; KBio1_001928; 2H-1-Benzopyran-7-ol, 3,4-dihydro-3-(3-hydroxy-2,4-dimethoxyphenyl)-8-methoxy-, (R)- |
C18H20O6 |
332.35 |
COC1=C(C(=C(C=C1)C2CC3=C(C(=C(C=C3)O)OC)OC2)OC)O |
|
TCMBANKIN024532 |
(S)-Cheilanthifoline |
(6aS)-9-methoxy-6,11,12,14-tetrahydro-2H,6aH-[1,3]dioxolo[4,5-h]isoquino[2,1-b]isoquinolin-8-ol; C05174; CHEBI:16233; 483-44-3; (6aS)-6,6a,11,14-Tetrahydro-8-methoxy-12H-benzo[a]-1,3-benzodioxolo[4,5-g]quinolizim-9-ol |
C19H19NO4 |
325.36 |
COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C5=C(C=C4)OCO5)O |
|
TCMBANKIN024554 |
3-methyl-6-sec-butyl-2,5-piperazinedione |
|
|
184.27 |
|
|
TCMBANKIN025252 |
N-[6-(9-acridinylamino)hexyl]benzamide |
N-[6-(acridin-9-ylamino)hexyl]benzamide |
|
397.56 |
|
|
TCMBANKIN025340 |
(E)-linalool oxide acetate pyr |
[(3S,6R)-2,2,6-trimethyl-6-vinyl-tetrahydropyran-3-yl] acetate; trans-Linalool oxide (pyranoid), acetate; [(3S,6R)-6-ethenyl-2,2,6-trimethyl-oxan-3-yl] ethanoate; [(3S,6R)-6-ethenyl-2,2,6-trimethyloxan-3-yl] acetate; trans-Linalool oxide acetate (pyranoid); acetic acid [(3S,6R)-2,2,6-trimethyl-6-vinyl-tetrahydropyran-3-yl] ester; acetic acid [(3S,6R)-2,2,6-trimethyl-6-vinyl-3-tetrahydropyranyl] ester |
C10H18O2 |
170.25 |
CC(=O)OC1CCC(OC1(C)C)(C)C=C |
|
TCMBANKIN025570 |
9-oxo-4-xanthenecarboxylic acid |
AIDS070074; 9-ketoxanthene-4-carboxylic acid; 9-Oxoxanthene-4-carboxylic acid; AIDS-070074 |
C14H8O4 |
240.21 g/mol |
C1=CC=C2C(=C1)C(=O)C3=C(O2)C(=CC=C3)C(=O)O |
|
TCMBANKIN025853 |
1,7-dimethyl-5-vinyl-9,10-dihydrophenanthrene-2,6-diol |
5-ethenyl-1,7-dimethyl-9,10-dihydrophenanthrene-2,6-diol |
C18H18O2 |
266.3 g/mol |
CC1=CC2=C(C3=C(CC2)C(=C(C=C3)O)C)C(=C1O)C=C |
|
TCMBANKIN026047 |
linalool oxide, trans-pyranoid |
(3R,6S)-2,2,6-trimethyl-6-vinyl-3-tetrahydropyranol; (3R,6S)-2,2,6-trimethyl-6-vinyl-tetrahydropyran-3-ol; linalool oxide IV (trans, pyranoid); (3R,6S)-6-ethenyl-2,2,6-trimethyl-oxan-3-ol; (3R,6S)-6-ethenyl-2,2,6-trimethyloxan-3-ol |
C10H18O2 |
170.25 |
CC1(C(CCC(O1)(C)C=C)O)C |
|
TCMBANKIN026084 |
4-(2,6,6-Trimethyl-1-cyclohexenl-yl)-3-buten-2-ol |
4-(2,6,6-trimethyl-1-cyclohexenal-yl)-3-buten-2-ol |
|
222.36 |
|
|
TCMBANKIN027150 |
BDF |
Fructose, pyranose form; (2R,3S,4R,5R)-2-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetrol; CHEBI:41005; Frutabs; 7660-25-5; (2R,3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol; ZINC03861095; Fructopyranose, beta-D-; beta-D-Fructopyranose; HSDB 526; BRN 1423189; 4-01-00-04402 (Beilstein Handbook Reference); (2R,3S,4R,5R)-2-methyloltetrahydropyran-2,3,4,5-tetrol |
C6H12O6 |
180.16 |
C1C(C(C(C(O1)(CO)O)O)O)O |
|
TCMBANKIN027615 |
Isopropyl caprate |
n-Capric acid isopropyl ester; AI3-33575; propan-2-yl decanoate; Decanoic acid, 1-methylethyl ester; decanoic acid isopropyl ester; capric acid isopropyl ester; EINECS 219-001-4; ISOPROPYL DECANOATE; 2311-59-3 |
C13H26O2 |
214.34 |
CCCCCCCCCC(=O)OC(C)C |
|
TCMBANKIN027871 |
(6R)-2-methyl-6-(4-methylphenyl)hept-2-en-4-one |
|
C15H20O |
216.32 |
|
|
TCMBANKIN028149 |
3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran |
3-[[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tet; 3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydr |
C39H50O20 |
838.8 |
|
|
TCMBANKIN028720 |
1-hydroxy-6-hydroxymethylanthracenequinone |
|
|
254.25 |
|
|
TCMBANKIN030197 |
NN-Dimethyldecanamide |
N,N-Dimethylcapramide; SBB008016; N,N-Dimethylcapylamide; N,N-Dimethyldecanamide; DECANAMIDE, N,N-DIMETHYL-; FR-0759; BRN 1906042; N,N-Dimethyldecanoamide; N,N-Dimethyldecan-1-amide; AI3-34960; EINECS 238-405-1; NSC 131411; 14433-76-2; NSC131411; WLN: 9VN1&1 |
C12H25NO |
199.33 |
CCCCCCCCCC(=O)N(C)C |
|
TCMBANKIN030927 |
7-hydroxy-5,8-dimethoxy-2-phenyl-chromone |
7-hydroxy-5,8-dimethoxy-2-phenylchromen-4-one; 7-hydroxy-5,8-dimethoxy-2-phenyl-4-chromenone; 7-hydroxy-5,8-dimethoxy-2-phenyl-chromen-4-one |
|
298.31 |
|
|
TCMBANKIN031009 |
1,7-dimethyl-9,10-dihydrophenanthrene-2,6-diol |
InChI=1/C16H16O2/c1-9-7-11-3-4-12-10(2)15(17)6-5-13(12)14(11)8-16(9)18/h5-8,17-18H,3-4H2,1-2H |
C16H16O2 |
240.3 g/mol |
CC1=CC2=C(C=C1O)C3=C(CC2)C(=C(C=C3)O)C |
|
TCMBANKIN031102 |
HEXYL BUTYRATE |
EINECS 220-136-6; Hexyl butanoate; Butanoic acid, hexyl ester; AI3-33290; butyric acid hexyl ester; n-Hexyl butanoate; FEMA No. 2568; n-Hexyl butyrate; BRN 1754469; 1-Hexyl butyrate; n-Hexyl n-butanoate; Butyric acid, hexyl ester; butanoic acid hexyl ester; Hexyl butyrate; W256811_ALDRICH; Hexyl butyrate (natural); 2639-63-6; W256803_ALDRICH |
C10H20O2 |
172.26 |
CCCCCCOC(=O)CCC |
|
TCMBANKIN031346 |
HXD |
Dodecanoic acid, 3-hydroxy-, D-(-)- (8CI); (3R)-3-hydroxylauric acid; 3-OH-DODECANOATE; LMFA01050251; 3R-hydroxy-dodecanoic acid; D-(-)-3-Hydroxydodecanoic acid; (R)-3-hydroxylauric acid; Dodecanoic acid, 3-hydroxy-, (R)-; CHEBI:43197; D-3-Hydroxydodecanoic acid; (3R)-3-Hydroxydodecanoic acid |
C12H24O3 |
216.32 g/mol |
CCCCCCCCCC(CC(=O)O)O |
|
TCMBANKIN032898 |
licochalcone G |
|
C21H22O5 |
354.4 g/mol |
CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=C(C=C(C=C2)O)O)OC)O |
|
TCMBANKIN032984 |
1,8-dihydroxy-3-methoxy-2,6-dimethyl-9,10-anthraquinone |
1,8-dihydroxy-3-methoxy-2,6-dimethylanthracene-9,10-dione; 1,8-dihydroxy-3-methoxy-2,6-dimethyl-anthracene-9,10-dione |
|
298.31 |
|
|
TCMBANKIN033042 |
kakkatin |
|
C16H12O5 |
284.26 |
COC1=C(C=C2C(=C1)OC=C(C2=O)C3=CC=C(C=C3)O)O |
|
TCMBANKIN033093 |
dihydroisotanshinoneⅠ |
|
278.32 |
20.912695 |
|
|
TCMBANKIN033430 |
7-hydroxy-8-methyl-4-vinyl-9,10-dihydrophenanthrene-1-carboxylic acid |
4-ethenyl-7-hydroxy-8-methyl-9,10-dihydrophenanthrene-1-carboxylic acid |
|
278.32 |
|
|
TCMBANKIN033679 |
Glepidotin B |
87440-56-0; C09753; glepidotin b; (2R,3R)-3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chroman-4-one; (2R,3R)-3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-4-chromanone; (2R,3R)-3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenylchroman-4-one |
C20H20O5 |
340.37 |
CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(C(O2)C3=CC=CC=C3)O)C |
|
TCMBANKIN033903 |
cis-3-Hexenyl butyrate |
3-Hexenyl butanoate, cis-; cis-Butyric acid, 3-hexenyl ester; cis-3-Hexen-1-yl butyrate; 3-Hexenyl butyrate, cis-; butanoic acid [(Z)-hex-3-enyl] ester; AI3-33202; 3-Hexenyl butanoate, (Z)-; W340200_ALDRICH; Butyric acid, 3-hexenyl ester, (Z)-; 3-Hexenyl butyrate, (Z)-; Butanoic acid, 3-hexenyl ester, (Z)-; [(Z)-hex-3-enyl] butanoate; (Z)-3-hexenyl butyrate; cis-3-Hexenyl butyrate (natural); butyric acid [(Z)-hex-3-enyl] ester; (Z)-Hex-3-enyl butyrate; Butanoic acid, (3Z)-3-hexenyl ester; beta,gamma-Hexenyl butyrate; 16491-36-4; EINECS 240-553-7; FEMA No. 3402 |
C10H18O2 |
170.25 |
CCCC(=O)OCCC=CCC |
|
TCMBANKIN034170 |
(1S,6R)-6-isopropyl-3-methyl-1-cyclohex-3-enol |
(1S,6R)-3-methyl-6-propan-2-ylcyclohex-3-en-1-ol; (1S,6R)-3-methyl-6-propan-2-yl-cyclohex-3-en-1-ol; (1S,6R)-6-isopropyl-3-methyl-cyclohex-3-en-1-ol |
C10H18O |
154.25 |
|
|
TCMBANKIN034284 |
dan-shexinkum a |
|
|
296.34 |
|
|
TCMBANKIN034546 |
(-)-Phillygenin |
|
C21H24O6 |
372.41 |
|
|
TCMBANKIN034575 |
Inermin |
C16229; (+)-Maackiain; 6H-(1,3)Dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol, 6a,12a-dihydro-, cis-(+-)-; 38822-02-5; 6a,12a-Dihydro-6H-(1,3)dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol; 19908-48-6 |
C16H12O5 |
284.26 |
C1C2C(C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5 |
|
TCMBANKIN034682 |
cynanversicoside g_qt 1 |
|
|
162.21 |
|
|
TCMBANKIN034808 |
beta-D-arabinopyranose |
ZINC01532588; CHEBI:46996; (2R,3S,4R,5R)-tetrahydropyran-2,3,4,5-tetrol; (2R,3S,4R,5R)-oxane-2,3,4,5-tetrol |
C5H10O5 |
150.13 |
C1C(C(C(C(O1)O)O)O)O |
|
TCMBANKIN034970 |
2-methyl-5-(1-methylethylidene)-cyclo-hexanone |
|
C10H16O |
152.23 |
|
|
TCMBANKIN034982 |
Myricanone |
Tricyclo(12.3.1.12,6)nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-; myricanone; 32492-74-3 |
C21H24O5 |
356.41 |
COC1=C2C=C(CCCCC(=O)CCC3=CC2=C(C=C3)O)C(=C1OC)O |
|
TCMBANKIN035160 |
O-acetyl-α-boswellic acid |
|
|
498.82 |
|
|
TCMBANKIN035244 |
scabrans G5_qt |
scabrans G4_qt; gentiopicrin_qt; gentiopicroside_qt; scabrans G3_qt |
C16H20O9 |
356.32 |
|
|
TCMBANKIN035425 |
andrographidine F_qt |
|
|
374.37 |
|
|
TCMBANKIN035502 |
d-Piperitone |
InChI=1/C10H16O/c1-7(2)9-5-4-8(3)6-10(9)11/h6-7,9H,4-5H2,1-3H; 2-Cyclohexen-1-one, 3-methyl-6-(1-methylethyl)-, (S)-; 89-81-6; alpha-Piperitone; (6S)-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one; (6S)-3-methyl-6-propan-2-ylcyclohex-2-en-1-one; (6S)-6-isopropyl-3-methyl-cyclohex-2-en-1-one; FEMA No. 2910; Piperitone, alpha-; LMPR01020066; (S)-piperitone; 2-Cyclohexen-1-one, 3-methyl-6-(1-methyethyl)-, (S)-; d-Piperitone (natural); C09885; (+)-Piperitone; 4-Isopropyl-1-methyl-1-cyclohexen-3-one; 6091-50-5; (6S)-3-methyl-6-propan-2-yl-cyclohex-2-en-1-one; CHEBI:41; 3-Methyl-6-(1-methylethyl)-2-cyclohexen-1-one, (S)-; (S)-3-methyl-6-(1-methylethyl)-2-cyclohexen-1-one; 6-isopropyl-3-methylcyclohex-2-en-1-one; PIPERITONE, D-; (6S)-6-isopropyl-3-methyl-1-cyclohex-2-enone |
C10H16O |
152.23 |
CC1=CC(=O)C(CC1)C(C)C |
|
TCMBANKIN035549 |
8-Octadecenoic acid |
2197-55-9; trans-8-elaidic acid; (E)-octadec-8-enoic acid; 8E-octadecenoic acid; LMFA01030071; trans-8-octadecenoic acid |
C18H34O2 |
282.46 |
CCCCCCCCCC=CCCCCCCC(=O)O |
|
TCMBANKIN036265 |
nonadec-10-enoic acid |
LMFA01030361; (E)-nonadec-10-enoic acid; 10E-nonadecenoic acid |
C19H36O2 |
296.49 |
CCCCCCCCC=CCCCCCCCCC(=O)O |
|
TCMBANKIN036321 |
Swerchirin |
1,8-dihydroxy-3,5-dimethoxy-9-xanthenone; 1,8-Dihydroxy-3,5-dimethoxyxanthen-9-one; 1,8-dihydroxy-3,5-dimethoxy-xanthen-9-one; 1,8-dihydroxy-3,5-dimethoxy-xanthone; swerchirin; 9H-Xanthen-9-one, 1,8-dihydroxy-3,5-dimethoxy- (9CI); 521-65-3; C10091; BRN 0313581; 5-18-05-00194 (Beilstein Handbook Reference); 1,8-Dihydroxy-3,5-dimethoxy-9H-xanthen-9-one; 5-O-Methylbellidifolin; Xanthen-9-one, 1,8-dihydroxy-3,5-dimethoxy-; 3,5-Dimethoxy-1,8-dihydroxyxanthone; Methylbellidifolin |
C15H12O6 |
288.25 |
COC1=C2C(=C(C=C1)O)C(=O)C3=C(C=C(C=C3O2)OC)O |
|
TCMBANKIN036358 |
7-methoxy-3-methyl-2,5-dihydroxy-9,10-dihydrophenanthrene |
|
|
256.32 |
|
|
TCMBANKIN036384 |
[(1R,2R,5R)-2-isopropyl-5-methyl-cyclohexyl] acetate |
[(1R,2R,5R)-5-methyl-2-propan-2-yl-cyclohexyl] ethanoate; 20777-36-0; 50539-17-8; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1R,2R,5R)-rel-; acetic acid [(1R,2R,5R)-2-isopropyl-5-methyl-cyclohexyl] ester; [(1R,2R,5R)-5-methyl-2-propan-2-ylcyclohexyl] acetate; acetic acid [(1R,2R,5R)-2-isopropyl-5-methylcyclohexyl] ester |
C12H22O2 |
198.3 |
CC1CCC(C(C1)OC(=O)C)C(C)C |
|
TCMBANKIN036395 |
1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol |
4-ethenyl-1,8-dimethyl-9,10-dihydrophenanthrene-2,7-diol |
|
266.36 |
|
|
TCMBANKIN036825 |
Honokiol |
VZ32385; 354H746; NCGC00163567-01; HMS2051C12; 11513CCO0N; {1,1'-Biphenyl]-2,4'-diol, 3,5-di-2-propenyl-; 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; ZINC00001536; STK801954; AIDS002243; FVYXIJYOAGAUQK-UHFFFAOYSA-N; AC-486; SMP2_000040; 5,3′ C10630; AX8008971; NSC-293100; AS-15333; W-2613; 3',5-diallyl-2,4'-biphenyldiol; AC1Q7A9U; MLS000759481; TR-014635; 564-73-8; SR-01000758208-5; 3',5-Dipropenyl-(1,1'-biphenyl)-2,4'-diol; J10347; NC00114; SAM001246690; Bio-0326; MLS001423980; CHEBI:5759; 3'',5-diallylbiphenyl-2,4''-diol; REGID_for_CID_72303; O900; MolPort-002-507-432; SCHEMBL133034; InChI=1/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H; BC205226; AN-15767; ANW-56605; MCULE-5001549020; ACN-035410; 3,5'-Diallyl-4,2'-dihydroxybiphenyl; Honokiol, >=98% (HPLC), powder; D04DQJ; CTK5J3931; BG01559998; SR-01000758208; BRD-K98493452-001-01-6; AC1L2HTG; AB0016711; AKOS005622639; 4-allyl-2-(3-allyl-4-hydroxy-phenyl)phenol; AT-5464; 5,3''''-Diallyl-biphenyl-2,4''''-diol; RTR-014635; cid_72303; 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol; 3',5-diallyl-[1,1'-biphenyl]-2,4'-diol; CHEMBL16901; 3',5-Diallyl-2,4'-dihydroxybiphenyl; 35354-74-6; 5,3′-Diallyl-2,4′-dihydroxybiphenyl; houpa; UNII-11513CCO0N; 3',5-di(prop-2-en-1-yl)biphenyl-2,4'-diol; CPD000387107; HY-N0003; HMS3393C12; Honokiol; Q-100425; FT-0601638; 5,3''-Diallyl-biphenyl-2,4''-diol; 3'',5-di-2-propenyl-1,1''-biphenyl-2,4''-diol; BBL027819; MFCD00016674; CCG-100864; ST24044036; AK-25837; [1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propen-1-yl-; Honokiol, analytical standard; AJ-08043; BDBM50157304; 3',1'-biphenyl)-2,4'-diol; 5,3'-Diallyl-biphenyl-2,4'-diol; NSC293100; NCGC00163567-03; BG00615873; 4CN-0876; NSC 293100; H4914_SIGMA; KS-00000NQF; 3',5'-Diallyl-2,4'-biphenyldiol; SC-17371; BN0719; NCGC00163567-02; LS-174528; BB_NC-1461; s2310; 5,3'-Diallyl-2,4'-dihydroxybiphenyl; API0002927; CS-1696; I06-0428; N1672; HMS2271J07; DTXSID30188845; SMR000387107; MLS001048916; AIDS-002243; HMS3656G03; Honokiol, HO; Honokiol, European Pharmacopoeia (EP) Reference Standard; ZINC1536; Honokiol,(S); MLS006011755; [1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propenyl-; 5,3′-Diallyl-2,4′-dihydroxydiphenyl; 4-allyl-2-(3-allyl-4-hydroxyphenyl)phenol; 3',5-Diallylbiphenyl-2,4'-diol |
|
266.334 |
|
|
TCMBANKIN036871 |
Glabridin |
AIDS-096010; 59870-68-7; 4-(3,4-Dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol; C10421; 4-((R)-8,8-Dimethyl-3,4-dihydro-2H,8H-benzo[1,2-b:4,3-b']dipyran-3-yl)-benzene-1,3-diol; 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]benzene-1,3-diol; 1,3-Benzenediol, 4-(3,4-dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-, (R)-; AIDS096010; 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]resorcinol; glabridin |
C20H20O4 |
324.37 |
CC1(C=CC2=C(O1)C=CC3=C2OCC(C3)C4=C(C=C(C=C4)O)O)C |
|
TCMBANKIN036911 |
Neocryptotanshinone |
Tanshinone V; CHEMBL1209715; AC1L4E98; ACMC-20cs2t; MolPort-039-338-876; AC1Q6N8U; CTK4A6611; 1-hydroxy-2-(1-hydroxypropan-2-yl)-8,8-dimethyl-5,6,7,8-tetrahydrophenanthrene-3,4-dione; 1-hydroxy-2-(1-hydroxypropan-2-yl)-8,8-dimethyl-6,7-dihydro-5H-phenanthrene-3,4-dione; Neocryptotanshinone; 121077-35-8; SCHEMBL14417697; 1,4-Phenanthrenedione,5,6,7,8-tetrahydro-3-hydroxy-2-[(1R)-2-hydroxy-1-methylethyl]-8,8-dimethyl-; 109664-02-0 |
|
314.376 |
|
|
TCMBANKIN036951 |
Tanshilactone |
tanshilactone |
C17H12O3 |
264.28 |
CC1=CC=CC2=C1C=CC3=C2C(=O)OC4=C3OC=C4C |
|
TCMBANKIN037811 |
15α-hydroxymansumbinone |
|
|
328.59 |
CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(C(C=C4)O)C)C)C |
|
TCMBANKIN038435 |
coniferin |
24-ethyl-5-bravery were steroids-3 beta alcohol; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenoxy]oxane-3,4,5-triol; 4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenyl beta-D-glucopyranoside; (2S,3R,4S,5S,6R)-2-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxy-phenoxy]-6-methylol-tetrahydropyran-3,4,5-triol; beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2-methoxyphenyl (VAN); (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxy-phenoxy]tetrahydropyran-3,4,5-triol; 531-29-3; ACon1_002032; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenoxy]tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxy-phenoxy]oxane-3,4,5-triol; MLS000563468; CHEBI:16220; Coniferin; Coniferyl alcohol beta-D-glucoside; C00761; MEGxp0_000873; SMR000470885 |
C16H22O8 |
342.341 |
c1(O[C@@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c(OC([H])([H])[H])c([H])c(\C([H])=C([H])\C([H])([H])O[H])c([H])c1[H] |
|
TCMBANKIN041369 |
7-acetoxy-8-hydroxy-9-isobutyryloxythymol |
|
C16H22O6 |
310.342 |
c1([H])c(C([H])([H])OC(C([H])([H])[H])=O)c([H])c(O[H])c([C@@](O[H])(C([H])([H])[H])C([H])([H])OC(C([H])(C([H])([H])[H])C([H])([H])[H])=O)c1[H] |
|
TCMBANKIN043470 |
Irigenin |
548-76-5; CHEMBL487013; 5,7-Dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone; MFCD00597047; C17957; MCULE-8768527753; CCG-214382; AK554317; 6O4NX37350; SR-05000002617; DTXSID90203285; 5,7,3'-Trimethoxy-6,4',5'-trimethoxyisoflavone; Irigenin; SCHEMBL554864; EINECS 208-958-3; 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxychromen-4-one; 4H-1-Benzopyran-4-one,5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-; NP-008092; UNII-6O4NX37350; 9569AF; SR-05000002617-1; AC1NUZ0N; CTK8J1984; AKOS030632868; MolPort-005-945-072; 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxy-phenyl)-6-methoxy-chromone; ZINC5732527; CHEBI:81409; LMPK12050417; 5,7,3'-trihydroxy-6,4',5'-trimethoxyisoflavone; 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxy-phenyl)-6-methoxy-chromen-4-one; KS-00000TYP; 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-chromenone |
|
360.315 |
|
|
TCMBANKIN043931 |
Epimedin B |
epimedin b |
C38H48O19 |
808.78 |
CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)OC6C(C(C(CO6)O)O)O)O)O |
|
TCMBANKIN044183 |
irisolidone |
5,7-dihydroxy-6-methoxy-3-(4-methoxyphenyl)-4-chromenone; Irisolidone; 5,7-dihydroxy-6-methoxy-3-(4-methoxyphenyl)chromone; 2345-17-7; C10471; 5,7-dihydroxy-6-methoxy-3-(4-methoxyphenyl)chromen-4-one |
C17H14O6 |
314.29 |
COC1=CC=C(C=C1)C2=COC3=C(C2=O)C(=C(C(=C3)O)OC)O |
|
TCMBANKIN044652 |
alpha-D-fructofuranose |
CHEBI:37720; (2S,3S,4S,5R)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol; (2S,3S,4S,5R)-2,5-dimethyloltetrahydrofuran-2,3,4-triol; (2S,3S,4S,5R)-2,5-bis(hydroxymethyl)tetrahydrofuran-2,3,4-triol |
C6H12O6 |
180.156 |
O([H])C([H])([H])[C@](O[H])(O[C@]([H])(C([H])([H])O[H])[C@@]1([H])O[H])[C@@]1([H])O[H] |
|
TCMBANKIN046419 |
7-Methoxy-2-methyl isoflavone |
7-methoxy-2-methyl-3-phenylchromen-4-one; MLS001048849; Oprea1_185553; 7-methoxy-2-methyl-3-phenyl-chromone; ZINC00520945; 7-Methoxy-2-methyl-3-phenyl-4H-chromen-4-one; MLS000556973; AIDS-130588; 7-methoxy-2-methyl isoflavone; 7-Methoxy-2-methyl-3-phenyl-chromen-4-one; SMR000148090; ST5071001; Oprea1_144261; AIDS130588; 7-methoxy-2-methyl-3-phenyl-4-chromenone; NSC605906 |
|
266.29 |
|
|
TCMBANKIN046723 |
melatonin |
|
C13H16N2O2 |
232.28 |
CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC |
|
TCMBANKIN049993 |
3-beta-Hydroxymethyllenetanshiquinone |
(7S)-7-hydroxy-1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-quinone; (7S)-7-hydroxy-1-methyl-6-methylidene-8,9-dihydro-7H-naphtho[8,7-g][1]benzoxole-10,11-dione; (7S)-7-hydroxy-1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione; 3-beta-hydroxymethyllenetanshiquinone |
C18H14O4 |
294.301 |
c12c(C(=C([H])[H])[C@@]([H])(O[H])C([H])([H])C1([H])[H])c([H])c([H])c3c2C(=O)C(=O)c(c(C([H])([H])[H])c([H])o4)c34 |
|
TCMBANKIN057938 |
XLS |
D-XYLOSE (LINEAR FORM); (2R,3S,4R)-2,3,4,5-tetrahydroxyvaleraldehyde; D-xylo-pentose; CHEBI:15936; (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal; D-Xyl; HSDB 3273; (2S,3R,4S,5R)-tetrahydropyran-2,3,4,5-tetrol; Xylose, pure; 141492-19-5; C02205; 25990-60-7; 2,3,4,5-Tetrahydroxypentanal; ZINC01529214; D-(+)-Xylose; Xylose, D- (8CI); (2S,3R,4S,5R)-oxane-2,3,4,5-tetrol; Xylose (VAN); alpha-D-xylopyranose; (+)-Xylose; tetrahydropyran-2,3,4,5-tetraol; CCRIS 1899; NSC 122762; FEMA No. 3606; BRN 1562108; XYLOPYRANOSE; Xylose, D-; (D)-XYLOSE; Xylomed; CHEBI:28518; 4-01-00-04223 (Beilstein Handbook Reference); C01394; D-Xylose (9CI); 133-56-2; EINECS 200-400-7; Xylo-Pfan; AI3-19010; 6763-34-4; EINECS 247-395-8; Xylose [USAN]; XYS |
C5H10O5 |
150.13 |
C(C(C(C(C=O)O)O)O)O |
|
TCMBANKIN058094 |
5-HMF |
5-(Hydroxymethyl)-2-furancarboxaldehyde; 5-18-01-00130 (Beilstein Handbook Reference); 2-Furancarboxaldehyde, 5-(hydroxymethyl)-; 2-Hydroxymethyl-5-furfural; BRN 0110889; 5-(Hydroxymethyl)-2-furancarbonal; CCRIS 3160; CBiol_000485; 67-47-0; NSC40738; SBB004259; 2-Furaldehyde, 5-(hydroxymethyl)-; 5-(Hydroxymethyl)-2-furaldehyde; 5-(hydroxymethyl)furan-2-carbaldehyde; Hydroxymethylfurfurole; 5-Hydroxymethylfurfural; 5-Hydroxymethylfuraldehyde; C11101; 5-(Hydroxymethyl)furfural; 5-Oxymethylfurfurole; InChI=1/C6H6O3/c7-3-5-1-2-6(4-8)9-5/h1-3,8H,4H; EINECS 200-654-9; W501808_ALDRICH; Hydroxymethylfurfuralaldehyde; 5-(Hydroxymethyl)-2-furfuraldehyde; ICCB3_000133; H40807_ALDRICH; Hydroxymethylfurfural; 5-Hydroxymethyl-2-furancarboxaldehyde; NCGC00091513-01; 55690_FLUKA; 5-Hydroxymethyl furaldehyde; 5-(Hyddroxymethyl)furfurole; 5-Hydroxymethyl-2-furaldehyde; 5-(Hydroxymethyl)-2-furfural; NSC 40738; 76330-16-0; Hydroxymethylfurfuraldehyde; 5-Hydroxymethyl-2-formylfuran; ZINC00900788; 5-Hydroxymethylfuran-2-aldehyde; 5-methylolfurfural; 5-hydroxymethylfuraldehyde; 5-hydroxymethyl furfural; 5-hydroxy methyl furfural; 5-hydroxymethylfurfural; 2-Furancarboxaldehyde,5-(hydroxymethyl); 5-hydroxymethyl furaldehyde; 5-hydroxymethyl-2-furfural; 5-(hydroxymethyl)-2-furfural; 5- hydroxymethylfurfural; 2-Furancarboxaldehyde , 5-(hydroxymethyl) |
C6H6O3 |
126.11 g/mol |
C1=C(OC(=C1)C=O)CO |
|
TCMBANKIN058180 |
naphthazarin |
5,8-dihydroxy-2,3-dihydronaphthalene-1,4-dione; A827266; SCHEMBL13568681; 1,4-Naphthalenedione, 2,3-dihydro-5,8-dihydroxy-; 5,8-bis(oxidanyl)-2,3-dihydronaphthalene-1,4-dione; 4988-51-6; 5,8-Dihydroxy-1,4-tetralindione; AKOS022505654; 5,8-dihydroxytetralin-1,4-dione; AJ-69959; DTXSID40450045; naphthazarin ; 2.3-Dihydro-naphthazarin; MCULE-8216200508; ZINC17111188; CTK1D0318; NSC344555; 1,4-Naphthalenedione, 5,8-dihydroxy-; AIDS-005214; 1,4-Naphthoquinone, 5,8-dihydroxy-; 5,8-Dihydroxy-1,4-naphthosemiquinone; Naphthazarin; 37790_FLUKA; InChI=1/C10H6O4/c11-5-1-2-6(12)10-8(14)4-3-7(13)9(5)10/h1-4,11-12; 388513_ALDRICH; 5,8-Dihydroxynaphthaquinone; ZINC00901191; 475-38-7; NSC 26647; 5,8-Dihydroxynaphthoquinone; C01938; Naphthazarone; NCI60_002143; 1,4-Naphthalenedione, 5,8-dihydroxy- (9CI); EINECS 207-495-4; AIDS005214; NSC26647; 5,8-dihydroxynaphthalene-1,4-dione; Dihydroxynaphthoquinone; 5,8-Dihydroxy-1,4-naphthalenedione; NAPTHAZARIN NPHZ; Naphthazarine; 5,8-Dihydroxy-1,4-naphthoquinone; CCRIS 6670; DHNQ |
C10H6O4 |
190.15 g/mol |
C1=CC(=C2C(=O)C=CC(=O)C2=C1O)O |
|
TCMBANKIN058367 |
indirubin |
NSC-105327; KBio2_000450; 2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one; 2-(2-oxo-3-indolinylidene)-3-indolinone; Couroupitine B; [.DELTA.2,3'-Biindoline]-2',3-dione; MLS000759416; 479-41-4; 5-24-08-00507 (Beilstein Handbook Reference); KBio3_000839; NSC105327; NSC 105327; (2E)-2-(2-ketoindolin-3-ylidene)pseudoindoxyl; KBioGR_000450; Indigopurpurin; KBioSS_000450; (2E)-2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one; indirubin ; (delta2,3'-Biindoline)-2',3-dione (8CI); 2-(2-ketoindolin-3-ylidene)pseudoindoxyl; (delta(sup 2,3')-BIINDOLINE)-2',3-DIONE; Indirubin; (2E)-2-(2-oxoindolin-3-ylidene)indolin-3-one; 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-; SMR000466311; 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro- (9CI); BRN 0088279; C.I. 73200; KBio2_005586; (2E)-2-(2-oxo-3-indolinylidene)-3-indolinone; Indigo Red; KBio2_003018; EM-A05-INDIRUBIN; 2-(2-oxoindolin-3-ylidene)indolin-3-one; KBio3_000840; Bio2_000395; Bio2_000875; (2Z)-2-(2-oxo-3-indolinylidene)-3-indolinone; (2Z)-2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one; IDI1_002150; BSPBio_001110; NCGC00163356-01; BiomolKI2_000073; NCGC00163356-02; NCGC00163356-03; BiomolKI_000069; (2Z)-2-(2-ketoindolin-3-ylidene)pseudoindoxyl; (2Z)-2-(2-oxoindolin-3-ylidene)indolin-3-one |
C16H10N2O2 |
262.26 |
C1=CC=C2C(=C1)C(=C(N2)O)C3=NC4=CC=CC=C4C3=O |
|
TCMBANKIN058390 |
tryptanthrine |
AC1L2K2A; SMR000386951; Indolo(2,1-b)quinazoline-6,12-dione; NSC-349447; MLS001049121; SR-01000521538-1; Indolo(2,1-b)quinazoline-6,12-dione (8CI)(9CI); FT-0733127; Couroupitine a; Tryptanthrin; KS-00000C3R; C-45803; Tryptantherin; NCGC00160337-02; GNF-PF-2691; NSC349447; AK-57813; TCMDC-125859; Tryptanthrin, >=98% (HPLC); NCI60_003113; ZB000930; DS-15687; KB-254423; SR-01000521538-4; ST047334; CHEMBL306946; CJ-00188; Indolo[2,1-b]quinazoline-6,12-dione; 5941AA; NCGC00160337-01!TRYPTANTHRINE; 13220-57-0; SCHEMBL2426211; STK078931; NCGC00160337-01; AKOS000671350; Bio-0284; HMS2271H05; Indolo[2,1-b]quizoline-6,12-dione; SY017117; 11-hydrobenzo[d]quinazolino[3,2-a]azolidine-6,12-dione; ANW-68868; ZINC33299; MCULE-7521697515; CTK0H6551; TRA0036916; SR-01000521538; J-006143; AX8156048; BDBM50240612; AC1Q1HJD; TC-157613; K-4146; Tryptanthrine; D0I9AT; MFCD00012073; GTPL8224; CCG-208326; NSC 349447; AJ-08570; CHEBI:9768; DTXSID90157431; VQQVWGVXDIPORV-UHFFFAOYSA-N; C10742; Oprea1_754264; Indolo[2,12-dione; MolPort-002-516-459; AC1L2K2A; indolo[2,1-b]quinazoline-6,12-quinone; SMR000386951; Indolo(2,1-b)quinazoline-6,12-dione; NSC-349447; MLS001049121; SR-01000521538-1; Indolo(2,1-b)quinazoline-6,12-dione (8CI)(9CI); FT-0733127; Couroupitine a; Tryptanthrin; KS-00000C3R; C-45803; Tryptantherin; NCGC00160337-02; GNF-PF-2691; NSC349447; AK-57813; TCMDC-125859; Tryptanthrin, >=98% (HPLC); NCI60_003113; ZB000930; DS-15687; KB-254423; SR-01000521538-4; ST047334; CHEMBL306946; CJ-00188; tryptanthrin ; Indolo[2,1-b]quinazoline-6,12-dione; 5941AA; NCGC00160337-01!TRYPTANTHRINE; 13220-57-0; SCHEMBL2426211; STK078931; NCGC00160337-01; AKOS000671350; Bio-0284; indolo[2,1- b]quinazoline alkaloid; HMS2271H05; indolo-[2,1-b]-quinazoline-6,12-dione; Indolo[2,1-b]quizoline-6,12-dione; SY017117; 11-hydrobenzo[d]quinazolino[3,2-a]azolidine-6,12-dione; ANW-68868; ZINC33299; MCULE-7521697515; CTK0H6551; TRA0036916; AIDS017287; SR-01000521538; J-006143; ZINC00033299; AX8156048; BDBM50240612; 6,12-dihydro-6, 12-dioxoindolo-(2,1-b)-quinazoline; AC1Q1HJD; TC-157613; K-4146; Tryptanthrine; D0I9AT; MFCD00012073; GTPL8224; CCG-208326; NSC 349447; AJ-08570; AIDS-017287; CHEBI:9768; DTXSID90157431; VQQVWGVXDIPORV-UHFFFAOYSA-N; C10742; Oprea1_754264; Indolo[2,12-dione; MolPort-002-516-459; tryptanthrin |
C15H8N2O2 |
248.24 g/mol |
C1=CC=C2C(=C1)C(=O)N3C4=CC=CC=C4C(=O)C3=N2 |
|
TCMBANKIN058470 |
NOJ |
19130-96-2; AIDS-000139; Bio1_001393; BSPBio_000993; 1-DEOXYNOJIRIMYCIN; DNM; Bio1_000415; NCGC00025085-02; 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-; Bio1_000904; 1-Deoxymannojirimycin; 1,5-Dideoxy-1,5-imino-D-glucitol; (2R,3R,4R,5S)-2-Hydroxymethyl-piperidine-3,4,5-triol; (2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol; AIDS000139; SMP2_000333; 70956-02-4; 1,5-Deoxy-1,5-imino-D-mannitol; 73285-50-4 (HCL); (2R,3R,4R,5S)-2-methylolpiperidine-3,4,5-triol; 1-DEOXY-NOJIRIMYCIN; DNJ; 3gbe; 2jke; 3gxt; 2pwd; 1- deoxynojirimycin; 1-deoxynojirimycin; 3qfz; 4iid; 1-deoxynojirimycin; 1-deoxynojirimicin |
C6H13NO4 |
163.17 g/mol |
C1C(C(C(C(N1)CO)O)O)O |
|
TCMBANKIN058472 |
ASO |
1,5-ANHYDROSORBITOL; (2R,3S,4R,5S)-2-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 154-58-5; 1,5-Anhydroglucitol; C07326; CHEBI:16070; Polygalytol; 1,5-Anhydro-D-glucitol; (2R,3S,4R,5S)-2-(hydroxymethyl)oxane-3,4,5-triol; 1,5-Anhydro-D-sorbitol; (2R,3S,4R,5S)-2-methyloltetrahydropyran-3,4,5-triol; EINECS 205-829-3; D-Glucitol, 1,5-anhydro- |
C6H12O5 |
164.16 |
C1C(C(C(C(O1)CO)O)O)O |
|
TCMBANKIN058473 |
L-arabinose |
l-arabinose;arabinose;ARA;Arabinose;(2R,3R,4S,5S)-oxane-2,3,4,5-tetrol; (2R,3R,4S,5S)-tetrahydropyran-2,3,4,5-tetrol; ZINC01532575; CHEBI:46987; alpha-L-arabinopyranose; C02479; beta-L-Arabinose |
C5H10O5 |
150.13 g/mol |
C1C(C(C(C(O1)O)O)O)O |
|
TCMBANKIN058574 |
(?)-regiolone |
(4r)-4,8-dihydroxy-α-tetralone |
C10H10O3 |
178.18 g/mol |
C1CC(=O)C2=C(C1O)C=CC=C2O |
|
TCMBANKIN058584 |
rengyolone |
rengynic acid;2-(1,4-dihydroxycyclohexanyl)-aceticacid |
C8H14O4 |
174.19 g/mol |
C1CC(CCC1O)(CC(=O)O)O |
|
TCMBANKIN058739 |
crocetin |
2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-, (all-E)- (8CI); C08588; (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate; AIDS-073359; 2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-;.alpha.-Crocetin; 8,8'-diapo-8,8'-carotenedioate; 8,8'-diapo-psi,psi-carotenedioate; AIDS073359; 2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-,(all-E)-; Crocetin; 27876-94-4; crocetin(2-); 8,8'-Diapocarotenedioic acid; NCI60_003871; 2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioic acid; LMPR01070223; CHEBI:62767; (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioic acid; 8,8'-Diapo-psi,psi-carotenedioic acid; EINECS 248-708-0; CCRIS 7484; Natural yellow 6; NSC 407300; CI 75100; 8,8'-diapocarotene-8,8'-dioate; 8,8'-diapocarotenedioate; crocetin dianion; α-crocetin |
C20H24O4 |
328.4 |
CC(=CC=CC=C(C)C=CC=C(C)C(=O)O)C=CC=C(C)C(=O)O |
|
TCMBANKIN058774 |
Icariin I |
icariin i; icariside I; icariside i |
C27H30O11 |
530.5 g/mol |
CC(=CCC1=C(C=C(C2=C1OC(=C(C2=O)O)C3=CC=C(C=C3)OC)O)OC4C(C(C(C(O4)CO)O)O)O)C |
|
TCMBANKIN058805 |
Anhydroicaritin |
118525-40-9; anhydroicaritin; 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one; 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromone; 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-4-chromenone |
C21H20O6 |
368.38 |
CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=C(C=C3)OC)O)C |
|
TCMBANKIN059169 |
neocryptotanshinone ii |
1-hydroxy-2,8,8-trimethyl-6,7-dihydro-5H-phenanthrene-3,4-dione; AC1NSZ0S;deoxyneocryptotanshinone |
C19H22O3 |
298.4 g/mol |
CC(C)C1=C(C2=C(C3=C(C=C2)C(CCC3)(C)C)C(=O)C1=O)O |
|
TCMBANKIN059208 |
trans-p-2-Menthen-1-ol |
(1S,4R)-4-isopropyl-1-methyl-cyclohex-2-en-1-ol; trans-p-2-menthen-1-ol; (1S,4R)-4-isopropyl-1-methyl-1-cyclohex-2-enol; (1S,4R)-1-methyl-4-propan-2-ylcyclohex-2-en-1-ol; (1S,4R)-1-methyl-4-propan-2-yl-cyclohex-2-en-1-ol;2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, trans-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, (1R,4S)-rel-; (1R,4S)-4-isopropyl-1-methyl-cyclohex-2-en-1-ol; EINECS 249-859-5; trans-1-Methyl-4-(1-methylethyl)-2-cyclohexen-1-ol; 29803-81-4; (1R,4S)-1-methyl-4-propan-2-ylcyclohex-2-en-1-ol; (1R,4S)-1-methyl-4-propan-2-yl-cyclohex-2-en-1-ol; (1R,4S)-4-isopropyl-1-methyl-1-cyclohex-2-enol; 117064-02-5;trans-4-(Isopropyl)-1-methylcyclohex-2-en-1-ol |
C10H18O |
154.25 |
CC(C)C1CCC(C=C1)(C)O |
|
TCMBANKIN059268 |
guineensine |
55038-30-7; (2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-isobutyltrideca-2,4,12-trienamide; (2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)trideca-2,4,12-trienamide; (2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-isobutyl-trideca-2,4,12-trienamide |
C24H33NO3 |
383.5 g/mol |
CC(C)CNC(=O)C=CC=CCCCCCCC=CC1=CC2=C(C=C1)OCO2 |
|
TCMBANKIN059932 |
chrysophanol |
|
C15H10O4 |
254.24 |
CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O |
|
TCMBANKIN059982 |
d-limonene |
|
C10H16 |
136.23 g/mol |
CC1=CCC(CC1)C(=C)C |
|
TCMBANKIN059985 |
alpha-terpinol |
|
C10H18O |
154.25 g/mol |
CC1=CCC(CC1)C(C)(C)O |
|
TCMBANKIN060373 |
thujylalcohol |
|
C10H18O |
154.25 g/mol |
CC1C2CC2(CC1O)C(C)C |
|
TCMBANKIN060450 |
d-menthone |
|
C10H18O |
154.25 g/mol |
CC1CCC(C(=O)C1)C(C)C |
|
TCMBANKIN060452 |
()-Neomenthol;(1R,2R,5S)-2-Isopropyl-5-methylcyclohexanol |
|
C10H20O |
156.27 |
CC1CCC(C(C1)O)C(C)C |
|
TCMBANKIN060473 |
dehydroagastol |
|
C21H26O4 |
342.4 g/mol |
CC1CCC2(C(C1=C)CC(=O)C3=C2C(=C(C(=C3O)C(=C)C)OC)O)C |
|
TCMBANKIN060575 |
alpha-gurjunene |
|
C15H24 |
204.35 g/mol |
CC1CCC2C(C2(C)C)C3=C(CCC13)C |
|
TCMBANKIN060589 |
Dihydronepetalactone |
|
C10H16O2 |
168.23 g/mol |
CC1CCC2C1C(=O)OCC2C |
|
TCMBANKIN060616 |
dihydrotanshinoneⅠ |
|
C18H14O3 |
45.043279 |
CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CC=C4C |
|
TCMBANKIN060617 |
1,2,5,6-tetrahydrotanshinone |
|
C18H16O3 |
280.3 g/mol |
CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCC=C4C |
|
TCMBANKIN060638 |
2-methylbutanoic acid |
|
C5H10O2 |
102.13 |
CCC(C)C(=O)O |
|
TCMBANKIN060879 |
Linolic acid |
|
C18H32O2 |
280.4 g/mol |
CCCCCC=CCC=CCCCCCCCC(=O)O |
|
TCMBANKIN060910 |
cis-9-hexadecenoic acid |
|
C16H30O2 |
254.41 g/mol |
CCCCCCC=CCCCCCCCC(=O)O |
|
TCMBANKIN060914 |
11-Octadecenoic acid |
|
C18H34O2 |
282.5 g/mol |
CCCCCCC=CCCCCCCCCCC(=O)O |
|
TCMBANKIN060926 |
Ethyl octoate |
|
C10H20O2 |
172.26 |
CCCCCCCC(=O)OCC |
|
TCMBANKIN060938 |
Isooleic acid |
|
C18H34O2 |
282.46 g/mol |
CCCCCCCC=CCCCCCCCCC(=O)O |
|
TCMBANKIN060945 |
Methyl nonylate |
|
C10H20O2 |
172.26 g/mol |
CCCCCCCCC(=O)OC |
|
TCMBANKIN060946 |
ethyl nonanoate |
|
C11H22O2 |
186.29 |
CCCCCCCCC(=O)OCC |
|
TCMBANKIN060978 |
Mnk |
|
C11H22O |
170.29 |
CCCCCCCCCC(=O)C |
|
TCMBANKIN060980 |
caproic acid;capric acid;n-decanoic acid;NON |
|
C10H20O2 |
172.26 g/mol |
CCCCCCCCCC(=O)O |
|
TCMBANKIN060981 |
Methyl caprate |
|
C11H22O2 |
186.29 |
CCCCCCCCCC(=O)OC |
|
TCMBANKIN060987 |
[10]-gingerol |
|
C21H34O4 |
350.49 g/mol |
CCCCCCCCCC(CC(=O)CCC1=CC(=C(C=C1)O)OC)O |
|
TCMBANKIN061038 |
Gaidic acid |
|
C16H30O2 |
254.41 g/mol |
CCCCCCCCCCCCCC=CC(=O)O |
|
TCMBANKIN061045 |
PENTADECYLIC ACID |
|
C15H30O2 |
242.4 g/mol |
CCCCCCCCCCCCCCC(=O)O |
|
TCMBANKIN061105 |
Eicosanoic acid |
|
C20H40O2 |
312.53 g/mol |
CCCCCCCCCCCCCCCCCCCC(=O)O |
|
TCMBANKIN061183 |
Decyl acetate |
|
C12H24O2 |
200.32 g/mol |
CCCCCCCCCCOC(=O)C |
|
TCMBANKIN061207 |
Di-n-butyl phthalate |
|
C16H22O4 |
278.34 g/mol |
CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC |
|
TCMBANKIN061215 |
n-butyl-β-D-fructopyranoside |
|
C10H20O6 |
237.27 g/mol |
CCCCOC1(C(C(C(CO1)O)O)O)CO |
|
TCMBANKIN061269 |
2,2,2-triethoxyethanol |
|
C8H18O4 |
178.23 g/mol |
CCOC(CO)(OCC)OCC |
|
TCMBANKIN061271 |
EA-fructofuranoside |
|
C8H16O6 |
208.21 |
CCOC1(C(C(C(O1)CO)O)O)CO |
|
TCMBANKIN061275 |
Ethyl glucoside |
|
C8H16O6 |
208.21 |
CCOC1C(C(C(C(O1)CO)O)O)O |
|
TCMBANKIN061486 |
5-hydroxy-3',4',6,7-tetramethoxyflavone |
2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxychromen-4-one; 21763-80-4; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-chromone; AIDS218321; 5-Hydroxy-3',4',6,7-tetramethoxyflavone; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-chromen-4-one; 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4-chromenone; AIDS-218321; 5-Hydroxy-6,7,3',4'-tetramethoxyflavone; HTMF; 5-hydroxy-3′,4′,6,7-tetramethoxyflavone; 5-hydroxy-6,7,3',4'-tetramethoxyflavone; 5-hydroxy-6,7,3 ', 4'-tetramethoxy flavone; AC1L48C3; 57296-14-7; 3'-O-methyl-eupatorin; 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one; BDBM50092614; DTXSID50176163; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxychromen-4-one; 3,5-dihydroxy-6,7,3',4'-tetramethoxyflavone; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-chromen-4-one; 5-Hydroxy-3',4',6,7-tetramethoxyflavone; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-chromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-; AK583634; QEWSAPKRFOFQIU-UHFFFAOYSA-N; HTMF; SCHEMBL3131502; 21763-80-4; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-; CTK4E7643; 5-hydroxy-6,7-dimethoxy-2-(3,4-dimethoxyphenyl)-4H-chromen-4-one; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-4-chromenone; CHEMBL226508; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxychromen-4-one; LMPK12111243; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-chromone; AKOS030553584; Belamcanidin; 6-Hydroxyluteolin 6,7,3',4'-tetramethyl ether; 5-Hydroxy-6,7,3',4'-tetramethoxyflavone; 4H-1-Benzopyran-4-one,2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-; 2-(3,4-Dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-4H-1-benzopyran-4-one; 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one #; 5-demethylsinensetin; belamcanidin; 3,5-Dihydroxy-6,7,3',4'-tetramethoxyflavone; belamcadin |
C19H18O7 |
358.3 g/mol |
COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC |
|
TCMBANKIN061547 |
(+)-isolariciresinol;(2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol;isolariciresinol |
26568-14-9; (6R,7R,8S)-8-(4-hydroxy-3-methoxy-phenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-ol; 47477-27-0; (6R,7R,8S)-8-(4-hydroxy-3-methoxyphenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-ol; (2R,3R,4S)-4-(4-hydroxy-3-methoxyphenyl)-2,3-bis(hydroxymethyl)-7-methoxy-6-tetralinol; 2,3-Naphthalenedimethanol, 1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6-methoxy-, (1S-(1alpha,2beta,3alpha))-; 548-29-8; Arbo 3; 1,2,3,4-Tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6-methoxy-2,3-naphthalenedimethanol; (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-2,3-bis(hydroxymethyl)-7-methoxy-tetralin-6-ol |
C20H24O6 |
360.4 |
COC1=C(C=C2C(C(C(CC2=C1)CO)CO)C3=CC(=C(C=C3)O)OC)O |
|
TCMBANKIN061589 |
chrysosplenelin;Chrysosplenetin |
5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-4-chromenone; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; chrysosplenetin; 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromone; Quercetagetin 3,6,7,3'-tetramethyl ether; 4H-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; Chrysosplenetin B; 603-56-5; 69234-29-3; C10030 |
C19H18O8 |
374.34 |
COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
|
TCMBANKIN061627 |
matairesinol |
41328-88-5; AIDS030806; (-)-Matairesinol; Matairesinol; 3R,4R-Bis((4-hydroxy-3-methoxyphenyl)methyl)dihydro-2(3H)-furanone; AIDS-030806; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxy-phenyl)methyl]tetrahydrofuran-2-one; ARTIGENIN CONGENER; (3R,4R)-3,4-bis(4-hydroxy-3-methoxy-benzyl)tetrahydrofuran-2-one; 580-72-3; DIBENZYLBUTYROLACTONE LIGNANOLIDE; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one; 40043_FLUKA; MEGxp0_001689; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxy-phenyl)methyl]oxolan-2-one; Arbo 5; C10682; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2-tetrahydrofuranone; (alphaR,betaR)-alpha,beta-Bis(4-hydroxy-3-methoxybenzyl)butyrolactone; ACon1_001075; 2(3H)-Furanone, dihydro-3,4-bis((4-hydroxy-3-methoxyphenyl)methyl)-, (3R-trans)-;(- )-matairesinol;MAX |
C20H22O6 |
358.4 g/mol |
COC1=C(C=CC(=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)O)OC)O |
|
TCMBANKIN061661 |
Swertiaperennin |
1,8-Dihydroxy-2,6-dimethoxyxanthen-9-one; 1,8-dihydroxy-2,6-dimethoxy-xanthen-9-one; Methylswertianin; 2-O-Methylswertianin; 1,8-dihydroxy-2,6-dimethoxy-xanthone; C10083; 1,8-dihydroxy-2,6-dimethoxy-9-xanthenone; 1,8-Dihydroxy-2,6-dimethoxy-9H-xanthen-9-one; 9H-Xanthen-9-one, 1,8-dihydroxy-2,6-dimethoxy- (9CI); BRN 1351740; Xanthen-9-one, 1,8-dihydroxy-2,6-dimethoxy-; 22172-17-4; 1,8-Dihydroxy-2,6-dimethoxyxanthone |
C15H12O6 |
288.25 g/mol |
COC1=C(C2=C(C=C1)OC3=CC(=CC(=C3C2=O)O)OC)O |
|
TCMBANKIN061665 |
hispidulin |
447H887; 5,7,4'-trihydroxy-6-methoxyflavone; Dinatin; 6-methoxyapigenin; LS-173226; CTK8G0189; NSC 122415; BDBM50049395; UNII-N7F61604C2; B6959; 4H-1-Benzopyran-4-one,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; hispidulin ; ACon1_000933; MLS000728540; NP-001963; ZINC5732241; 4',7-Trihydroxy-6-methoxyflavone; MCULE-3882973229; SCHEMBL514926; HMS3344G13; C10058; 4?,5,7-Trihydroxy-6-methoxyflavone; PubChem SID: 26725244; W1618; MolPort-001-740-838; NSC122415; KS-00001FKN; MEGxp0_000683; Hispidulin; Oprea1_873387; cid_5281628; methoxyapigenin; BRD-K72066874-001-01-0; Flavone,5,7-trihydroxy-6-methoxy-; TCMDC-123942; N7F61604C2; FT-0697687; 1447-88-7; Scutellarein 6-methyl ether; CCRIS 8484; HMS2223A03; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one; 6-methylscutellarein; HY-N1950; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one #; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one; Flavone, 4',5,7-trihydroxy-6-methoxy-; SMR000445653; AN-49210; 4H-1-Benzopyran-4-one, 5, 7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-6-methoxy-chromen-4-one; hispidulin(dinatin); AKOS004110694; NCGC00167728-02; 6-methoxy apigenin; 5,7,4''-Trihydroxy-6-methoxyflavone; HUL; 4CN-1206; DTXSID30162786; NCI60_000530; CS-6502; IHFBPDAQLQOCBX-UHFFFAOYSA-N; ST024778; 4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-; CHEBI:75902; AC1NQYRM; BG01592767; C-56393; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; NCGC00167728-01; CHEMBL293776; NSC-122415; NCGC00169216-01; Q-100165; 6-O-Methylapigenin; 4H-1-Benzopyran-4-one,5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; LMPK12111159; 4',5,7-Trihydroxy-6-methoxyflavone; Dinatin; NCI60_000530; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one; AIDS126680; NSC122415; MEGxp0_000683; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-chromenone; Hispidulin; ST024778; Oprea1_873387; 4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-; NSC 122415; ZINC00113457; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one; Flavone, 4',5,7-trihydroxy-6-methoxy-; SMR000445653; AIDS-126680; ACon1_000933; 4H-1-Benzopyran-4-one, 5, 7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; MLS000728540; 6-O-Methylapigenin; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromone; 1447-88-7; C10058; Scutellarein 6-methyl ether; 4',5,7-Trihydroxy-6-methoxyflavone; 6-methoxyapigenin |
C16H12O6 |
300.26 g/mol |
COC1=C(C2=C(C=C1O)OC(=CC2=O)C3=CC=C(C=C3)O)O |
|
TCMBANKIN061828 |
5-hydroxy-4',7-dimethoxy-flavone; Flavone der. |
AIDS-071717; 5-Hydroxy-4',7-dimethoxy-flavone; Genkwanin 4'-methyl ether; 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one; 5-Hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-benzopyrone; NSC94547; Flavone, 5-hydroxy-4',7-dimethoxy- (8CI); 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-; Flavone, 5-hydroxy-4,7-dimethoxy-; 5-Hydroxy-4',7-dimethoxyflavone; 5128-44-9; 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-chromenone; FLAVONE,5-HYDROXY-4-7-DIMETHOXY; AIDS071717; 5'-Hydroxy-7,4'-dimethoxyflavone; NSC 94547; C10019; Apigenin dimethylether; EINECS 225-867-4; 4',7-Dimethylapigenin; 5-Hydroxy-7,4'-dimethoxyflavone; 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)- (9CI); Apigenin 7,4'-dimethyl ether; Apigenin 4',7-dimethyl ether; Flavone, 5-hydroxy-4',7-dimethoxy-; 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromone |
C17H14O5 |
298.29 g/mol |
COC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OC)O |
|
TCMBANKIN061845 |
olmelin |
Biochanin-A; NSC123538; Genistein 4-methyl ether; 5,7-dihydroxy-3-(4-methoxyphenyl)chromone; 5,7-dihydroxy-3-(4-methoxyphenyl)-4-chromenone; Genistein 4′-methyl ether; CCRIS 5449; KBioGR_002274; Isoflavone, 5,7-dihydroxy-4'-methoxy- (8CI); Spectrum4_001927; KBio2_005811; BSPBio_002776; Spectrum3_001098; KBio1_001027; NSC 123538; NCGC00017369-01; NINDS_001027; Spectrum2_000047; ST057580; Biochanin A; 5,7-Dihydroxy-4'-methoxyisoflavone; NCGC00022428-03; AIDS012225; C00814; KBioSS_000675; KBio3_001996; SMR000059116; Spectrum5_001624; MLS000069443; AIDS-012225; CHEBI:17574; NCI60_000558; 5,7-Dihydroxy-3-p-methoxyphenyl-4H-chromen-4-one; IDI1_001027; KBio2_003243; 5,7-dihydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one; 4'-Methoxy-5,7-dihydroxy isoflavone; SPECTRUM10100003; 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one; SPBio_000173; Spectrum_000195; EINECS 207-744-7; D2016_SIGMA; Biochanin; 4'-Methylgenistein; SMP1_000045; Isoflavone, 5,7-dihydroxy-4'-methoxy-; KBio2_000675; ZINC00016666; 5,7-Dihydroxy-4′-methoxyisoflavone; NCGC00022428-05; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-methoxyphenyl)-; Oprea1_038096; TNP00319; Biochanine A; 491-80-5; DivK1c_001027 |
C16H12O5 |
284.26 |
COC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3C2=O)O)O |
|
TCMBANKIN061878 |
HMO |
3-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; Isoformononetin; 3-(4-hydroxyphenyl)-7-methoxychromen-4-one; 4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-methoxy-; 7-methoxy-4'-hydroxyisoflavone; C12125; 4'-HYDROXY-7-METHOXYISOFLAVONE; 3-(4-hydroxyphenyl)-7-methoxy-4-chromenone; 3-(4-hydroxyphenyl)-7-methoxy-chromone;isoformononetin |
C16H12O4 |
268.26 g/mol |
COC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O |
|
TCMBANKIN061902 |
dambonitol |
dambonite |
C8H16O6 |
208.21 |
COC1C(C(C(C(C1O)OC)O)O)O |
滇IICP备16009434号-1 |
Dai SX Lab